Terms: = Head and neck cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Clinical Outcome
6 results:
1. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy.
Xie C; Yang P; Zhang X; Xu L; Wang X; Li X; Zhang L; Xie R; Yang L; Jing Z; Zhang H; Ding L; Kuang Y; Niu T; Wu S
EBioMedicine; 2019 Jun; 44():289-297. PubMed ID: 31129097
[TBL] [Abstract] [Full Text] [Related]
2. Impact Exerted by Nutritional Risk Screening on clinical outcome of Patients with Esophageal cancer.
Wang R; Cai H; Li Y; Chen C; Cui Y
Biomed Res Int; 2018; 2018():7894084. PubMed ID: 29780831
[TBL] [Abstract] [Full Text] [Related]
3. Diffuse proliferative glomerulonephritis associated with cetuximab, an epidermal growth factor receptor inhibitor.
Sasaki K; Anderson E; Shankland SJ; Nicosia RF
Am J Kidney Dis; 2013 Jun; 61(6):988-91. PubMed ID: 23474009
[TBL] [Abstract] [Full Text] [Related]
4. Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma.
Tan EL; Selvaratnam G; Kananathan R; Sam CK
BMC Cancer; 2006 Sep; 6():227. PubMed ID: 16995954
[TBL] [Abstract] [Full Text] [Related]
5. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma.
Hölting T; Möller P; Tschahargane C; Meybier H; Buhr H; Herfarth C
World J Surg; 1990; 14(3):291-4; discussion 295. PubMed ID: 2368431
[TBL] [Abstract] [Full Text] [Related]
